Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionCharles Schwab Investment Management Inc
Latest Disclosed Ownership790,812 shares
Latest Disclosed Value $ 23,495,025
Charles Schwab Investment Management Inc reports 2.15% decrease in ownership of TVTX / Travere Therapeutics, Inc.

On May 15, 2026 - Charles Schwab Investment Management Inc filed a 13F-HR form disclosing ownership of 790,812 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $23,495,025 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 808,189 shares of Travere Therapeutics, Inc.. This represents a change in shares of -2.15% during the quarter. The current value of the position is $35,744,702 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 790,812 -17,377 -2.15 23,495 -23.92 0.0036
2026-02-13 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 808,189 -40,167 -4.73 30,881 52.31 0.0048
2025-11-10 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 848,356 77,060 9.99 20,276 77.62 0.0032
2025-08-12 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 771,296 86,753 12.67 11,415 -6.95 0.0020
2025-09-15 2025-03-31 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 684,543 22,940 3.47 12,267 6.44 0.0023
2025-05-09 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 684,543 22,940 12,267 0.0023
2025-02-06 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 661,603 94,194 16.60 11,525 45.19 0.0021
2024-11-12 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 567,409 -1,184 -0.21 7,938 69.87 0.0015
2024-08-12 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 568,593 13,121 2.36 4,674 9.13 0.0009
2024-05-09 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 555,472 15,985 2.96 4,283 -11.69 0.0010
2024-02-06 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 539,487 -26,432 -4.67 4,850 -4.15 0.0012
2023-11-08 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 565,919 25,566 4.73 5,059 -39.04 0.0014
2023-08-10 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 540,353 38,023 7.57 8,300 -26.54 0.0024
2023-05-12 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 502,330 39,219 8.47 11,297 16.00 0.0034
2023-02-13 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 463,111 269 0.06 9,739 -14.61 0.0031
2022-11-14 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 462,842 -7,305 -1.55 11,405 0.11 0.0041
2022-08-15 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 470,147 -1,733 -0.37 11,392 -6.32 0.0040
2022-05-13 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 471,880 13,560 2.96 12,161 -14.52 0.0037
2022-02-11 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 458,320 -5,559 -1.20 14,227 26.46 0.0042
2021-11-16 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 463,879 -176,236 -27.53 11,250 20.45 0.0037
2021-08-16 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 640,115 -35,535 -5.26 9,340 -44.64 0.0031
2021-05-17 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 675,650 117,340 21.02 16,871 10.87 0.0062
2021-02-16 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 558,310 34,708 6.63 15,217 57.43 0.0060
2020-11-13 2020-09-30 13F RETROPHIN COM 761299106 523,602 120,248 29.81 9,666 17.41 0.0044
2020-08-20 2020-06-30 13F/A-1 RETROPHIN COM 761299106 403,354 57,292 16.56 8,233 63.03 0.0040
2020-08-14 2020-06-30 13F RETROPHIN COM 761299106 403,354 57,292 8,233 3,976.9186
2020-05-15 2020-03-31 13F RETROPHIN COM 761299106 346,062 5,551 1.63 5,050 4.43 0.0030
2020-02-07 2019-12-31 13F RETROPHIN COM 761299106 340,511 3,076 0.91 4,836 23.65 0.0026
2019-11-08 2019-09-30 13F RETROPHIN COM 761299106 337,435 18,671 5.86 3,911 -38.93 0.0023
2019-08-09 2019-06-30 13F RETROPHIN COM 761299106 318,764 26,358 9.01 6,404 -3.23 0.0039
2019-05-14 2019-03-31 13F RETROPHIN COM 761299106 292,406 17,807 6.48 6,618 6.48 0.0042
2019-02-14 2018-12-31 13F RETROPHIN COM 761299106 274,599 5,331 1.98 6,215 -19.67 0.0048
2018-11-13 2018-09-30 13F RETROPHIN COM 761299106 269,268 -32,266 -10.70 7,737 -5.88 0.0052
2018-08-08 2018-06-30 13F RETROPHIN COM 761299106 301,534 5,998 2.03 8,220 24.38 0.0060
2018-05-07 2018-03-31 13F RETROPHIN COM 761299106 295,536 5,791 2.00 6,609 8.26 0.0051
2018-01-17 2017-12-31 13F RETROPHIN COM 761299106 289,745 71 0.02 6,105 -15.33 0.0048
2017-11-13 2017-09-30 13F RETROPHIN COM 761299106 289,674 11,986 4.32 7,210 33.89 0.0063
2017-08-01 2017-06-30 13F RETROPHIN COM 761299106 277,688 73,067 35.71 5,385 42.54 0.0051
2017-05-15 2017-03-31 13F RETROPHIN COM 761299106 204,621 40,330 24.55 3,778 21.44 0.0038
2017-02-13 2016-12-31 13F RETROPHIN COM 761299106 164,291 32,183 24.36 3,111 5.21 0.0034
2016-11-14 2016-09-30 13F RETROPHIN COM 761299106 132,108 11,187 9.25 2,957 37.28 0.0035
2016-08-18 2016-06-30 13F/A-1 RETROPHIN COM 761299106 120,921 2,040 1.72 2,154 32.64 0.0027
2016-08-15 2016-06-30 13F RETROPHIN COM 761299106 120,921 2,154
2016-05-05 2016-03-31 13F RETROPHIN COM 761299106 118,881 -7,979 -6.29 1,624 -33.66 0.0021
2016-02-11 2015-12-31 13F RETROPHIN COM 761299106 126,860 3,233 2.62 2,448 -2.28 0.0033
2015-11-13 2015-09-30 13F RETROPHIN COM 761299106 123,627 21,319 20.84 2,505 -26.15 0.0037
2015-08-14 2015-06-30 13F RETROPHIN COM 761299106 102,308 47,484 86.61 3,392 158.14 0.0047
2015-05-14 2015-03-31 13F RETROPHIN COM 761299106 54,824 2,436 4.65 1,314 104.67 0.0018
2015-02-17 2014-12-31 13F RETROPHIN COM 761299106 52,388 7,281 16.14 642 57.74 0.0010
2014-11-10 2014-09-30 13F RETROPHIN COM 761299106 45,107 12,079 36.57 407 4.90 0.0007
2014-07-30 2014-06-30 13F RETROPHIN COM 761299106 33,028 33,028 388 0.0007
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.